Mouse models of escherichia coli O157:H7 infection and shiga toxin injection

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  O'Brien, Alison D ^a   Mohawk, Krystle L ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; SHIGA TOXIN; STREPTOMYCIN SULFATE;

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CITROBACTER RODENTIUM; COMMENSAL ESCHERICHIA COLI; DISEASE MODEL; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; EXPERIMENTAL INFECTION; EXPERIMENTAL MOUSE; GERMFREE ANIMAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTOXICATION; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PROTEIN CALORIE MALNUTRITION; REVIEW; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; ANIMAL; MICROBIOLOGY; MOUSE; PATHOLOGY;

ANIMALIA; ESCHERICHIA COLI;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; MICE; SHIGA TOXINS;

EID: 79952214271     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/258185     Document Type: Review

References (164)

1. Karmali M. A., Petric M., Lim C., The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli Journal o (Pubitemid 15094592)
2. Karmali M. A., Steele B. T., Petric M., Lim C., Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools The Lancet 1983 1 8325 619 620 (Pubitemid 13152343)
3. Riley L. W., Remis R. S., Helgerson S. D., Hemmorhagic colitis associated with a rare Escherichia coli serotype New England Journal of Medicine 1983 308 12 681 685 (Pubitemid 13157770)
4. Rangel J. M., Sparling P. H., Crowe C., Griffin P. M., Swerdlow D. L., Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 19822002 Emerging Infectious Diseases 2005 11 4 603 609 (Pubitemid 40462912)
5. Michino H., Araki K., Minami S., Takaya S., Sakai N., Miyazaki M., Akio O., Yanagawa H., Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts American Journal of Epidemiology 1999 150 8 787 796 (Pubitemid 29482831)
6. Cody S. H., Glynn M. K., Farrar J. A., Cairns K. L., Griffin P. M., Kobayashi J., Fyfe M., Hoffman R., King A. S., Lewis J. H., Swaminathan B., Bryant R. G., Vugia D. J., An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice Annals of Internal Medicine 1999 130 3 202 209 (Pubitemid 29078781)
7. CDC, Update on Multi-State Outbreak of E. coli O157:H7 Infections From Fresh Spinach, October 6, 2006. October 2006, http://www.cdc.gov/foodborne/ ecolispinach/100606.htm
8. CDC, Multistate Outbreak of E. coli O157:H7 Infections Linked to Eating Raw Refrigerated Prepackaged Cookie Dough. August 2009, http://www.cdc.gov/ ecoli/2009/0807.html
9. Mead P. S., Slutsker L., Dietz V., McCaig L. F., Bresee J. S., Shapiro C., Griffin P. M., Tauxe R. V., Food-related illness and death in the United States Emerging Infectious Diseases 1999 5 5 607 625 (Pubitemid 29493763)
10. Hancock D. D., Besser T. E., Rice D. H., Kaper J. B., O'Brien A. D., Ecology of Escherichia coli O157:H7 in cattle and impact of management practices Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 85 91
11. Griffin P. M., Tauxe R. V., The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome Epidemiologic Reviews 1991 13 60 98
12. Meng J., Doyle M. P., Kaper J. B., O'Brien A. D., Microbiology of Shiga toxin-producing Escherichia coli in foods Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 92 108
13. Griffin P. M., Blaser M. J., Smith P. D., Ravdin J. I., Greenberg H. B., Guerrant R. L., Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli Infections of the Gastrointestinal Tract 1995 New York, NY, USA Raven Press 739 761
14. Brandt M. L., O'Regan S., Rousseau E., Yazbeck S., Surgical complications of the hemolytic-uremic syndrome Journal of Pediatric Surgery 1990 25 11 1109 1112 (Pubitemid 20368633)
15. Manning S. D., Motiwala A. S., Springman A. C., Qi W., Lacher D. W., Ouellette L. M., Mladonicky J. M., Somsel P., Rudrik J. T., Dietrich S. E., Zhang W., Swaminathan B., Alland D., Whittam T. S., Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks Proceedings of the National Academy of Sciences of the United States of America 2008 105 12 4868 4873 (Pubitemid 351753838)
16. Fox J. T., Thomson D. U., Drouillard J. S., Thornton A. B., Burkhardt D. T., Emery D. A., Nagaraja T. G., Efficacy of Escherichia coli O157:H7 siderophore receptor/porin proteins-based vaccine in feedlot cattle naturally shedding E. coli O157 Foodborne Pathogens and Disease 2009 6 7 893 899
17. Moxley R. A., Smith D. R., Luebbe M., Erickson G. E., Klopfenstein T. J., Rogan D., Escherichia coli O157:H7 vaccine dose-effect in feedlot cattle Foodborne Pathogens and Disease 2009 6 7 879 884
18. Smith D. R., Moxley R. A., Klopfenstein T. J., Erickson G. E., A randomized longitudinal trial to test the effect of regional vaccination within a cattle feedyard on Escherichia coli O157:H7 rectal colonization, fecal shedding, and hide contamination Foodborne Pathogens and Disease 2009 6 7 885 892
19. Thomson D. U., Loneragan G. H., Thornton A. B., Lechtenberg K. F., Emery D. A., Burkhardt D. T., Nagaraja T. G., Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle Foodborne Pathogens and Disease 2009 6 7 871 877
20. Melton-Celsa A. R., Smith M. J., O'Brien A. D., Bock A., Curtiss R. III, Kaper J. B., Shiga toxins: potent poisons, pathogenicity determinants, and pharmacological agents EcoSalEscherichia coli and Salmonella: Cellular and Molecular Biology 2005 Washington, DC, USA ASM Press
21. O'Brien A. D., Holmes R. K., Shiga and Shiga-like toxins Microbiological Reviews 1987 51 2 206 220 (Pubitemid 17082511)
22. Wen S. X., Teel L. D., Judge N. A., O'Brien A. D., Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge Vaccine 2006 24 8 1142 1148 (Pubitemid 43202260)
23. Smith M. J., Teel L. D., Carvalho H. M., Melton-Celsa A. R., O'Brien A. D., Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2 Vaccine 2006 24 19 4122 4129
24. Smith M. J., Carvalho H. M., Melton-Celsa A. R., O'Brien A. D., The 13C4 monoclonal antibody that neutralizes Shiga toxin type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide Infection and Immunity 2006 74 12 6992 6998 (Pubitemid 44913174)
25. Louise C. B., Obrig T. G., Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells Journal of Infectious Diseases 1995 172 5 1397 1401
26. Boerlin P., McEwen S. A., Boerlin-Petzold F., Wilson J. B., Johnson R. P., Gyles C. L., Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans Journal of Clinical Microbiology 1999 37 3 497 503 (Pubitemid 29091254)
27. Ostroff S. M., Tarr P. I., Neill M. A., Lewis J. H., Hargret-Bean N., Kobayashi J. M., Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections Journal of Infectious Diseases 1989 160 6 994 998 (Pubitemid 20002767)
28. Scotland S. M., Willshaw G. A., Smith H. R., Rowe B., Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2 Epidemiology and Infection 1987 99 3 613 624 (Pubitemid 18034334)
29. Lingwood C. A., Role of verotoxin receptors in pathogenesis Trends in Microbiology 1996 4 4 147 153 (Pubitemid 26135305)
30. Lingwood C. A., Verotoxins and their glycolipid receptors Advances in Lipid Research 1993 25 189 211
31. Johannes L., Rmer W., Shiga toxins from cell biology to biomedical applications Nature Reviews Microbiology 2010 8 2 105 116
32. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K., Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins European Journal of Biochemistry 1988 171 1-2 45 50 (Pubitemid 18042873)
33. Saxena S. K., O'Brien A. D., Ackerman E. J., Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes Journal of Biological Chemistry 1989 264 1 596 601 (Pubitemid 19027648)
34. Obrig T. G., Shiga toxin mode of action in E. coli O157:H7 disease Frontiers in Bioscience 1997 2 d635 d642
35. Nataro J. P., Kaper J. B., Diarrheagenic Escherichia coli Clinical Microbiology Reviews 1998 11 1 142 201 (Pubitemid 28046019)
36. Levine M. M., Xu J., Kaper J. B., A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome Journal of Infectious Diseases 1987 156 1 175 182 (Pubitemid 17089400)
37. Burland V., Shao Y., Perna N. T., Plunkett G., Sofia H. J., Blattner F. R., The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7 Nucleic Acids Research 1998 26 18 4196 4204 (Pubitemid 28418378)
38. Tatsuno I., Horie M., Abe H., Miki T., Makino K., Shinagawa H., Taguchi H., Kamiya S., Hayashi T., Sasakawa C., toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype Infection and Immunity 2001 69 11 6660 6669 (Pubitemid 32995421)
39. Schmidt H., Karch H., Beutin L., The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli -hemolysin family FEMS Microbiology Letters 1994 117 2 189 196 (Pubitemid 24097098)
40. Karch H., Heeseman J., Laufs R., A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells Infection and Immunity 1987 55 2 455 461 (Pubitemid 17004128)
41. Frankel G., Phillips A. D., Rosenshine I., Dougan G., Kaper J. B., Knutton S., Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements Molecular Microbiology 1998 30 5 911 921 (Pubitemid 28550116)
42. Feng P., Weagant S. D., Monday S. R., Genetic analysis for virulence factors in Escherichia coli O104:H21 that was implicated in an outbreak of hemorrhagic colitis Journal of Clinical Microbiology 2001 39 1 24 28 (Pubitemid 32059562)
43. Paton A. W., Woodrow M. C., Doyle R. M., Lanser J. A., Paton J. C., Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic- uremic syndrome Journal of Clinical Microbiology 1999 37 10 3357 3361 (Pubitemid 29455234)
44. Cornick N. A., Booher S. L., Moon H. W., Intimin facilitates colonization by Escherichia coli O157:H7 in adult ruminants Infection and Immunity 2002 70 5 2704 2707 (Pubitemid 34408420)
45. Donnenberg M. S., Tzipori S., McKee M. L., O'Brien A. D., Alroy J., Kaper J. B., The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model Journal of Clinical Investigation 1993 92 3 1418 1424 (Pubitemid 23273920)
46. Judge N. A., Mason H. S., O'Brien A. D., Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces Infection and Immunity 2004 72 1 168 175 (Pubitemid 38018174)
47. McKee M. L., Melton-Celsa A. R., Moxley R. A., Francis D. H., O'Brien A. D., Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells Infection and Immunity 1995 63 9 3739 3744
48. Sinclair J. F., Dean-Nystrom E. A., O'Brien A. D., The established intimin receptor Tir and the putative eucaryotic intimin receptors nucleolin and 1 integrin localize at or near the site of enterohemorrhagic Escherichia coli O157:H7 adherence to enterocytes in vivo Infection and Immunity 2006 74 2 1255 1265 (Pubitemid 43185565)
49. Tzipori S., Gunzer F., Donnenberg M. S., De Montigny L., Kaper J. B., Donohue- Rolfe A., The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection Infection and Immunity 1995 63 9 3621 3627
50. Woods J. B., Schmitt C. K., Darnell S. C., Meysick K. C., O'Brien A. D., Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli Journal of Infectious Diseases 2002 185 4 550 554 (Pubitemid 34142819)
51. Frankel G., Lider O., Hershkoviz R., Paul Mould A., Kachalsky S. G., Candy D. C. A., Cahalon L., Humphries M. J., Dougan G., The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to integrins Journal of Biological Chemistry 1996 271 34 20359 20364 (Pubitemid 26281803)
52. Sinclair J. F., O'Brien A. D., Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin- of enterohemorrhagic Escherichia coli O157:H7 Journal of Biological Chemistry 2002 277 4 2876 2885 (Pubitemid 34953321)
53. Sinclair J. F., O'Brien A. D., Intimin types,, and bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor Journal of Biological Chemistry 2004 279 32 33751 33758 (Pubitemid 39063024)
54. Tarr P. I., Bilge S. S., Kaper J. B., O'Brien A. D., Intimin-independent adherence mechanisms of Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 157 162
55. Monnens L., Savage C. O., Taylor C. M., Kaper J. B., O'Brien A. D., Pathophysiology of hemolytic-uremic syndrome Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 287 292
56. Madara J. L., Stafford J., Dharmsathaphorn K., Carlson S., Structural analysis of a human intestinal epithelial cell line Gastroenterology 1987 92 5, part 1 1133 1145 (Pubitemid 17055900)
57. Acheson D. W. K., Moore R., De Breucker S., Lincicome L., Jacewicz M., Skutelsky E., Keusch G. T., Translocation of shiga toxin across polarized intestinal cells in tissue culture Infection and Immunity 1996 64 8 3294 3300 (Pubitemid 26256179)
58. Izumikawa K., Hirakata Y., Yamaguchi T., Takemura H., Maesaki S., Tomono K., Igimi S., Kaku M., Yamada Y., Kohno S., Kamihira S., Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin Journal of Antimicrobial Chemotherapy 1998 42 3 341 347 (Pubitemid 28442448)
59. Acheson D. W. K., Lincicome L. L., Jacewicz M. S., Kaper J. B., O'Brien A. D., Shiga toxin interaction with intestinal epithelial cells Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 140 147
60. Hammond T. G., Hammond J. M., Optimized suspension culture: the rotating-wall vessel American Journal of Physiology 2001 281 1 F12 F25
61. Nickerson C. A., Goodwin T. J., Terlonge J., Ott C. M., Buchanan K. L., Uicker W. C., Emami K., LeBlanc C. L., Ramamurthy R., Clarke M. S., Vanderburg C. R., Hammond T., Pierson D. L., Three-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar typhimurium pathogenesis Infection and Immunity 2001 69 11 7106 7120 (Pubitemid 32995472)
62. Unsworth B. R., Lelkes P. I., Growing tissues in microgravity Nature Medicine 1998 4 8 901 907 (Pubitemid 28364028)
63. Carvalho H. M., Teel L. D., Goping G., O'Brien A. D., A three-dimensional tissue culture model for the study of attach and efface lesion formation by enteropathogenic and enterohaemorrhagic Escherichia coli Cellular Microbiology 2005 7 12 1771 1781 (Pubitemid 41685270)
64. Baines D., Masson L., McAllister T., Escherichia coli O157:H7-secreted cytotoxins are toxic to enterocytes and increase Escherichia coli O157:H7 colonization of jejunum and descending colon in cattle Canadian Journal of Animal Science 2008 88 1 41 50 (Pubitemid 351691294)
65. Chong Y., Fitzhenry R., Heuschkel R., Torrente F., Frankel G., Phillips A. D., Human intestinal tissue tropism in Escherichia coli O157:H7initial colonization of terminal ileum and Peyer's patches and minimal colonic adhesion ex vivo Microbiology 2007 153 3 794 802 (Pubitemid 46444377)
66. Girard F., Batisson I., Frankel G. M., Harel J., Fairbrother J. M., Interaction of enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence Infection and Immunity 2005 73 9 6005 6016 (Pubitemid 41193039)
67. Girard F., Dziva F., Van Diemen P., Phillips A. D., Stevens M. P., Frankel G., Adherence of enterohemorrhagic Escherichia coli O157, O26, and O111 strains to bovine intestinal explants ex vivo Applied and Environmental Microbiology 2007 73 9 3084 3090 (Pubitemid 46718594)
68. Phillips A. D., Navabpour S., Hicks S., Dougan G., Wallis T., Frankel G., Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine Gut 2000 47 3 377 381
69. Tesh V. L., Burris J. A., Owens J. W., Gordon V. M., Wadolkowski E. A., O'Brien A. D., Samuel J. E., Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice Infection and Immunity 1993 61 8 3392 3402 (Pubitemid 23223431)
70. Armstrong G. D., Mulvey G. L., Marcato P., Griener T. P., Kahan M. C., Tennent G. A., Sabin C. A., Chart H., Pepys M. B., Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome Journal of Infectious Diseases 2006 193 8 1120 1124
71. Bentancor L. V., Bilen M., Brando R. J. F., Ramos M. V., Ferreira L. C. S., Ghiringhelli P. D., Palermo M. S., A DNA vaccine encoding the enterohemorragic Escherichia coli shiga-like toxin 2 A and B subunits confers protective immunity to shiga toxin challenge in the murine model Clinical and Vaccine Immunology 2009 16 5 712 718
72. Sheoran A. S., Chapman-Bonofiglio S., Harvey B. R., Mukherjee J., Georgiou G., Donohue-Rolfe A., Tzipori S., Human antibody against Shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications Infection and Immunity 2005 73 8 4607 4613 (Pubitemid 41105615)
73. Sauter K. A. D., Melton-Celsa A. R., Larkin K., Troxell M. L., O'Brien A. D., Magun B. E., Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody Infection and Immunity 2008 76 10 4469 4478
74. Melton-Celsa A. R., O'Brien A. D., Animal models for STEC-mediated disease Methods in Molecular Medicine 2003 73 291 305
75. Eaton K. A., Friedman D. I., Francis G. J., Tyler J. S., Young V. B., Haeger J., Abu-Ali G., Whittam T. S., Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice Infection and Immunity 2008 76 7 3054 3063
76. Karpman D., Council H., Svensson M., Scheutz F., Aim P., Svanborg C., The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection Journal of Infectious Diseases 1997 175 3 611 620 (Pubitemid 27086165)
77. Kurioka T., Yunou Y., Kita E., Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice Infection and Immunity 1998 66 4 1726 1734 (Pubitemid 128471540)
78. Shimizu K., Asahara T., Nomoto K., Tanaka R., Hamabata T., Ozawa A., Takeda Y., Development of a lethal Shiga toxin-producing Escherichia coli -infection mousemodel using multiple mitomycin C treatment Microbial Pathogenesis 2003 35 1 1 9 (Pubitemid 36809184)
79. Wadolkowski E. A., Burris J. A., O'Brien A. D., Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 Infection and Immunity 1990 58 8 2438 2445 (Pubitemid 20228222)
80. Mohawk K. L., Melton-Celsa A. R., Zangari T., Carroll E. E., O'Brien A. D., Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora Microbial Pathogenesis 2010 48 3-4 131 142
81. Zotta E., Lago N., Ochoa F., Repetto H. A., Ibarra C., Development of an experimental hemolytic uremic syndrome in rats Pediatric Nephrology 2008 23 4 559 567
82. Garca A., Bosques C. J., Wishnok J. S., Feng Y., Karalius B. J., Butterton J. R., Schauer D. B., Rogers A. B., Fox J. G., Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli Journal of Infectious Diseases 2006 193 8 1125 1134
83. Beery J. T., Doyle M. P., Schoeni J. L., Colonization of chicken cecae by Escherichia coli associated with haemorrhagic colitis Applied and Environmental Microbiology 1985 49 2 310 315 (Pubitemid 15136457)
84. Sueyoshi M., Nakazawa M., Experimental infection of young chicks with attaching and effacing Escherichia coli Infection and Immunity 1994 62 9 4066 4071 (Pubitemid 24264359)
85. Tzipori S., Wachsmuth I. K., Chapman C., The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets Journal of Infectious Diseases 1986 154 4 712 716 (Pubitemid 16032426)
86. Dean-Nystrom E. A., Stoffregen W. C., Bosworth B. T., Moon H. W., Pohlenz J. F., Early attachment sites for shiga-toxigenic Escherichia coli O157:H7 in experimentally inoculated weaned calves Applied and Environmental Microbiology 2008 74 20 6378 6384
87. Fenwick B. W., Cowan L. A., Kaper J. B., O'Brien A. D., Canine model of hemolytic-uremic syndrome Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 268 277
88. Taylor F. B., Tesh V. L., DeBault L., Li A., Chang A. C. K., Kosanke S. D., Pysher T. J., Siegler R. L., Characterization of the baboon responses to Shiga-like toxin. Descriptive study of a new primate model of toxic responses to Stx-1 American Journal of Pathology 1999 154 4 1285 1299 (Pubitemid 29169762)
89. Kang G., Pulimood A. B., Koshi R., Hull A., Acheson D., Rajan P., Keusch G. T., Mathan V. I., Mathan M. M., A monkey model for enterohemorrhagic Escherichia coli infection Journal of Infectious Diseases 2001 184 2 206 210 (Pubitemid 32614052)
90. Moxley R. A., Francis D. H., Kaper J. B., O'Brien A. D., Overview of animal models Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 249 260
91. Dean-Nystrom E. A., Bosworth B. T., Moon H. W., Kaper J. B., O'Brien A. D., Bovine infection with Shiga toxin-producing Escherichia coli Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains 1998 Washington, DC, USA ASM Press 261 267
92. Cowan L. A., Hertzke D. M., Fenwick B. W., Andreasen C. B., Clinical and clinicopathologic abnormalities in Greyhounds with cutaneous and renal glomerular vasculopathy: 18 cases (19921994) Journal of the American Veterinary Medical Association 1997 210 6 789 793 (Pubitemid 127507447)
93. Garca A., Marini R. P., Feng Y., Vitsky A., Knox K. A., Taylor N. S., Schauer D. B., Fox J. G., A naturally occurring rabbit model of enterohemorrhagic Escherichia coli -induced disease Journal of Infectious Diseases 2002 186 11 1682 1686 (Pubitemid 35379649)
94. Lindgren S. W., Melton A. R., O'Brien A. D., Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model Infection and Immunity 1993 61 9 3832 3842 (Pubitemid 23260057)
95. Fujii J., Kita T., Yoshida S. I., Takeda T., Kobayashi H., Tanaka N., Ohsato K., Mizuguchi Y., Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice Infection and Immunity 1994 62 8 3447 3453 (Pubitemid 24232132)
96. Isogai E., Isogai H., Takeshi K., Nishikawa T., Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain Microbiology and Immunology 1998 42 2 125 128 (Pubitemid 28101046)
97. Conlan J. W., Perry M. B., Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7 Canadian Journal of Microbiology 1998 44 8 800 805
98. Taguchi H., Takahashi M., Yamaguchi H., Osaki T., Komatsu A., Fujioka Y., Kamiya S., Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6 Journal of Medical Microbiology 2002 51 4 336 343 (Pubitemid 34252656)
99. Nagano K., Taguchi K., Hara T., Yokoyama S. I., Kawada K., Mori H., Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice Microbiology and Immunology 2003 47 2 125 132 (Pubitemid 36240891)
100. Brando R. J. F., Miliwebsky E., Bentancor L., Deza N., Baschkier A., Ramos M. V., Fernndez G. C., Meiss R., Rivas M., Palermo M. S., Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains Clinical and Experimental Immunology 2008 153 2 297 306 (Pubitemid 351989167)
101. Myhal M. L., Laux D. C., Cohen P. S., Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice European Journal of Clinical Microbiology 1982 1 3 186 192 (Pubitemid 12061075)
102. Meynell G. G., Subbaiah T. V., Antibacterial mechanisms of the mouse gut. I. Kinetics of infection by Salmonella typhimurium in normal and streptomycin-treated mice studied with abortive transductants British Journal of Experimental Pathology 1963 44 197 208
103. Miller C. E., Wong K. H., Feeley J. C., Forlines M. E., Immunological conversion of Vibrio chorlerae in gnotobiotic mice Infection and Immunity 1972 6 5 739 742
104. Savage D. C., Microbial ecology of the gastrointestinal tract Annual Review of Microbiology 1977 31 107 133
105. Wadolkowski E. A., Laux D. C., Cohen P. S., Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus Infection and Immunity 1988 56 5 1030 1035
106. Tzipori S., Gibson R., Montanaro J., Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic Escherichia coli in piglets and the role of plasmid-mediated factors Infection and Immunity 1989 57 4 1142 1150 (Pubitemid 19087860)
107. Asahara T., Shimizu K., Nomoto K., Hamabata T., Ozawa A., Takeda Y., Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7 Infection and Immunity 2004 72 4 2240 2247 (Pubitemid 38419939)
108. Teel L. D., Melton-Celsa A. R., Schmitt C. K., O'Brien A. D., One of two copies of the gene for the activatable Shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage Infection and Immunity 2002 70 8 4282 4291 (Pubitemid 34790937)
109. Melton-Celsa A. R., Darnell S. C., O'Brien A. D., Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice Infection and Immunity 1996 64 5 1569 1576 (Pubitemid 26129817)
110. Funatogawa K., Ide T., Kirikae F., Saruta K., Nakano M., Kirikae T., Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice Microbiology and Immunology 2002 46 11 761 766 (Pubitemid 35428952)
111. Gagnon M., Kheadr E. E., Dabour N., Richard D., Fliss I., Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice International Journal of Food Microbiology 2006 111 1 26 33 (Pubitemid 44219061)
112. Gamage S. D., Strasser J. E., Chalk C. L., Weiss A. A., Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin Infection and Immunity 2003 71 6 3107 3115 (Pubitemid 36637532)
113. Babiuk S., Asper D. J., Rogan D., Mutwiri G. K., Potter A. A., Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice Microbial Pathogenesis 2008 45 1 7 11
114. Gu J., Liu Y., Yu S., Wang H., Wang Q., Yi Y., Zhu F., Yu X. J., Zou Q., Mao X., Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice Microbes and Infection 2009 11 10-11 835 841
115. Uhlich G. A., Keen J. E., Elder R. O., Variations in the csgD promoter of Escherichia coli O157:H7 associated with increased virulence in mice and increased invasion of HEp-2 cells Infection and Immunity 2002 70 1 395 399 (Pubitemid 34028640)
116. Tilden J. Jr., Young W., McNamara A. M., Custer C., Boesel B., Lambert-Fair M. A., Majkowski J., Vugia D., Werner S. B., Hollingsworth J., Morris J. G., A new route of transmission for Escherichia coli: infection from dry fermented salami American Journal of Public Health 1996 86 8 1142 1145 (Pubitemid 26271542)
117. Isogai E., Isogai H., Kimura K., Hayashi S., Kubota T., Fujii N., Takeshi K., Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 Strain Infection and Immunity 1998 66 1 197 202 (Pubitemid 28018820)
118. Cimolai N., Morrison B. J., Carter J. E., Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome Pediatrics 1992 90 4 616 621
119. Sawamura S., Tanaka K., Koga Y., Therapeutic effects of antibiotics against enterohemorrhagic Escherichia coli (EHEC) O157:H7 (O157) infection: in vivo analysis using germfree mice The Journal of the Japanese Association for Infectious Diseases 1999 73 10 1054 1063
120. Aiba Y., Ishikawa H., Shimizu K., Noda S., Kitada Y., Sasaki M., Koga Y., Role of internalization in the pathogenicity of shiga toxin-producing Escherichia coli infection in a gnotobiotic murine model Microbiology and Immunology 2002 46 11 723 731 (Pubitemid 35428948)
121. Isogai E., Isogai H., Hayashi S., Kubota T., Kimura K., Fujii N., Ohtani T., Sato K., Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection Microbiology and Immunology 2000 44 2 89 95 (Pubitemid 30133679)
122. Isogai E., Isogai H., Hirose K., Hayashi S., Oguma K., In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection Current Microbiology 2001 42 4 248 251 (Pubitemid 32210495)
123. Isogai E., Isogai H., Hirose K., Kubota T., Kimura K., Fujii N., Hayashi S., Takeshi K., Oguma K., Therapeutic effect of anti-TNF- antibody and levofloxacin (LVFX) in a mouse model of enterohemorrhagic Escherichia coli 0157 infection Comparative Immunology, Microbiology and Infectious Diseases 2001 24 4 217 231 (Pubitemid 33014657)
124. Takahashi M., Taguchi H., Yamaguchi H., Osaki T., Komatsu A., Kamiya S., The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice FEMS Immunology and Medical Microbiology 2004 41 3 219 226 (Pubitemid 38757869)
125. Jeon B., Itoh K., Production of shiga toxin by a luxS mutant of Escherichia coli O157:H7 in vivo and in vitro Microbiology and Immunology 2007 51 4 391 396 (Pubitemid 46641674)
126. Kolling G. L., Matthews K. R., Examination of recovery in vitro and in vivo of nonculturable Escherichia coli O157:H7 Applied and Environmental Microbiology 2001 67 9 3928 3933 (Pubitemid 33641680)
127. LeBlanc J., Fliss I., Matar C., Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus -fermented milk Clinical and Diagnostic Laboratory Immunology 2004 11 6 1171 1181 (Pubitemid 39540862)
128. Mundy R., Girard F., FitzGerald A. J., Frankel G., Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium FEMS Microbiology Letters 2006 265 1 126 132 (Pubitemid 44715453)
129. Sheng H., Knecht H. J., Kudva I. T., Hovde C. J., Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants Applied and Environmental Microbiology 2006 72 8 5359 5366
130. Luperchio S. A., Schauer D. B., Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia Microbes and Infection 2001 3 4 333 340 (Pubitemid 32385783)
131. Tschape H., Prager R., Streckel W., Fruth A., Tietze E., Bohme G., Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school: green butter as the infection source Epidemiology and Infection 1995 114 3 441 450
132. Lai X. H., Xu J. G., Liu B. Y., Experimental infection of specific-pathogen-free mice with enterohemorrhagic Escherichia coli 0157:H7 Microbiology and Immunology 1991 35 7 515 524
133. Tth I., Csk M., Emody L., Spontaneous antibiotic resistance mutation associated pleiotropic changes in Escherichia coli O157:H7 Acta Veterinaria Hungarica 2003 51 1 29 44 (Pubitemid 36338332)
134. Gao X., Cai K., Shi J., Liu H., Hou X., Tu W., Xiao LE., Wang Q., Wang
135. Lindgren S. W., Samuel J. E., Schmitt C. K., O'Brien A. D., The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II- related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality Infection and Immunity 1994 62 2 623 631 (Pubitemid 24033783)
136. Paton A. W., Bourne A. J., Manning P. A., Paton J. C., Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric shiga-like toxin type II operons Infection and Immunity 1995 63 7 2450 2458
137. Paton J. C., Paton A. W., Survival rate of mice after transient colonization with Escherichia coli clones carrying variant Shiga-like toxin type II operons Microbial Pathogenesis 1996 20 6 377 383 (Pubitemid 26201640)
138. Nakagawa I., Nakata M., Yamamura T., Wakisaka S., Kawabata S., Hamada S., Infection and pathogenesis of a murine strain of Escherichia coli with genetically introduced Shiga toxin type I operon in conventional mice Microbial Pathogenesis 2002 33 2 63 72
139. Keepers T. R., Psotka M. A., Gross L. K., Obrig T. G., A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease Journal of the American Society of Nephrology 2006 17 12 3404 3414 (Pubitemid 44865283)
140. Psotka M. A., Obata F., Rolling G. L., Gross L. K., Ajsaleem M., Satchell S. C., Mathieson P. W., Obrig T. G., Shiga toxin 2 targets the murine renal collecting duct epithelium Infection and Immunity 2009 77 3 959 969
141. Barrett T. J., Potter M. E., Wachsmuth I. K., Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice Infection and Immunity 1989 57 11 3434 3437 (Pubitemid 19259873)
142. O'Brien A. D., LaVeck G. D., Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli Infection and Immunity 1983 40 2 675 683 (Pubitemid 13133282)
143. Yuhas Y., Weizman A., Dinari G., Ashkenazi S., An animal model for the study of neurotoxicity of bacterial products and application of the model to demonstrate that Shiga toxin and lipopolysaccharide cooperate in inducing neurologic disorders Journal of Infectious Diseases 1995 171 5 1244 1249
144. Ikeda M., Ito S., Honda M., Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin Pediatric Nephrology 2004 19 5 485 489 (Pubitemid 38594284)
145. Palermo M., Alves-Rosa F., Rubel C., Fernndez G. C., Fernndez-Alonso G., Alberto F., Rivas M., Isturiz M., Pretreatment of mice with lipopolysaccharide (LPS) or IL-1 exerts dose-dependent opposite effects on Shiga toxin-2 lethality Clinical and Experimental Immunology 2000 119 1 77 83 (Pubitemid 30064594)
146. Suzuki K., Tateda K., Matsumoto T., Gondaira F., Tsujimoto S., Yamaguchi K., Effects of interaction between Escherichia coli verotoxin and lipopolysaccharide on cytokine induction and lethality in mice Journal of Medical Microbiology 2000 49 10 905 910
147. Rasooly R., Do P. M., Shiga toxin Stx2 is heat-stable and not inactivated by pasteurization International Journal of Food Microbiology 2010 136 3 290 294
148. Rasooly R., Do P. M., Griffey S. M., Vilches-Moure J. G., Friedman M., Ingested shiga toxin 2 (stx2) causes histopathological changes in kidney, spleen, and thymus tissues and mortality in mice Journal of Agricultural and Food Chemistry 2010 58 16 9281 9286
149. Robinson C. M., Sinclair J. F., Smith M. J., O'Brien A. D., Shiga toxin of enterohemorrhagic Escherichia coli type 0157:H7 promotes intestinal colonization Proceedings of the National Academy of Sciences of the United States of America 2006 103 25 9667 9672 (Pubitemid 43955882)
150. Toledo C. C., Rogers T. J., Svensson M., Tati R., Fischer H., Svanborg C., Karpman D., Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7 American Journal of Pathology 2008 173 5 1428 1439
151. Mohawk K. L., Melton-Celsa A. R., Robinson C. M., O'Brien A. D., Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7 Vaccine 2010 28 30 4777 4785
152. Kojima Y., Fukumoto S., Furukawa K., Okajima T., Wiels J., Yokoyama K., Suzuk Y., Urano T., Ohta M., Furukawa K., Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids Journal of Biological Chemistry 2000 275 20 15152 15156 (Pubitemid 30337238)
153. Zumbrun S. D., Hanson L., Sinclair J. F., Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate shiga toxin receptor globotetraosylceramide Infection and Immunity 2010 78 11 4488 4499
154. Boyd B., Lingwood C., Verotoxin receptor glycolipid in human renal tissue Nephron 1989 51 2 207 210 (Pubitemid 19037693)
155. Eisenhauer P. B., Chaturvedi P., Fine R. E., Ritchie A. J., Pober J. S., Cleary T. G., Newburg D. S., Tumor necrosis factor alpha increases human cerebral endothelial cell Gb and sensitivity to Shiga toxin Infection and Immunity 2001 69 3 1889 1894 (Pubitemid 32187651)
156. Kasai K., Galton J., Terasaki P. I., Tissue distribution of the P(k) antigen as determined by a monoclonal antibody Journal of Immunogenetics 1985 12 4-5 213 220 (Pubitemid 16140624)
157. Lingwood C. A., Verotoxin-binding in human renal sections Nephron 1994 66 1 21 28 (Pubitemid 23355572)
158. Obata F., Tohyama K., Bonev A. D., Kolling G. L., Keepers T. R., Gross L. K., Nelson M. T., Sato S., Obrig T. G., Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons Journal of Infectious Diseases 2008 198 9 1398 1406
159. Oosterwijk E., Kalisiak A., Wakka J. C., Scheinberg D. A., Old L. J., Monoclonal antibodies against Gal 1-4Gal 1-4Glc (P(k), CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors International Journal of Cancer 1991 48 6 848 854
160. Uchida H., Kiyokawa N., Taguchi T., Horie H., Fujimoto J., Takeda T., Shiga toxins induce apoptosis in pulmonary epithelium-derived cells Journal of Infectious Diseases 1999 180 6 1902 1911
161. Okuda T., Tokuda N., Numata S. I., Ito M., Ohta M., Kawamura K., Wiels J., Urano T., Tajima O., Furukawa K., Furukawa K., Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins Journal of Biological Chemistry 2006 281 15 10230 10235 (Pubitemid 43864560)
162. Fujii Y., Numata S. I., Nakamura Y., Honda T., Furukawa K., Urano T., Wiels J., Uchikawa M., Ozaki N., Matsuo S. I., Sugiura Y., Furukawa K., Murine glycosyltransferases responsible for the expression of globo-series glycolipids: CDNA structures, mRNA expression, and distribution of their products Glycobiology 2005 15 12 1257 1267 (Pubitemid 41724330)
163. Fujii J., Iuchi Y., Okada F., Fundamental roles of reactive oxygen species and protective mechanisms in the female reproductive system Reproductive Biology and Endocrinology 2005 3
164. Rutjes N. W. P., Binnington B. A., Smith C. R., Maloney M. D., Lingwood C. A., Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model Kidney International 2002 62 3 832 845 (Pubitemid 35316712